Professional Documents
Culture Documents
Satairapan - NCP-DRUG STUDY 19
Satairapan - NCP-DRUG STUDY 19
Satairapan - NCP-DRUG STUDY 19
S.Y. 2023-24
Submitted To:
Prof. Maria Fe Dimdam RN
Clinical Instructor
Submitted By:
Michelle C. Satairapan
BSN3-301N
NURSING PRIORITY
DRUG STUDY
Respiratory:
Sinusitis,
Pharyngitis
Others:
Rhabdomyolis
is with acute
renal failure,
arthyalgia,
and myalgia.
GENERIC MECHAN INDICATIO CONTRAIN ADVERSE NURSING
NAME & DRUG IS M OF N D EFFECTS/ CONSIDERATIO
BRAND CLASSIF ACTION ICATION SIDE NS AND
NAME IC EFFECTS INTERVENTION
ATION:
GENERIC Nutrition - -Protein NOT SIDE -Evaluate for an!
NAME: al Normalize energy ADVISED EFFECTS: contraindications
Formula s malnutrition TO
α- metabolic RECEIVE - -Take drug as
ketoanalogue process -Pretention D ARE Hypercalcimia prescribed.
and THOSE
BRAND - treatment WHO ADVERSE -Taken with
NAME: EFFECTS:
Promotes o- HAVE: meals to allow
recycling conditions proper absorption
Renalog -Increase
product caused b! If you are of amino acids.
excHange modi-ied or allergic to calcium
, insu--icient this level -Educate the
(rotein medicine patient about
-Reduces metabolis or any possible side
ion m in cronic other effects and how
concentra renal ingredient to recognize
tio n failure. of Renolog them.
Potassiu Tablet.
m, -Give with food if
magnesiu If you have GI upset occurs.
m and a high
phosphat level of
e. calcium in
the blood.
-Frequently
If you assess for serum
have calcium levels.
deficient
protein
metabolis
m.
Diarrhea
Swelling of
lymph
glands
Joint Pain
Back pain
Fainting
ASSESSMENT FORM